XTENT Financial Statements
XTENT Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
XTENT Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (42.2) | (26.2) | (14.4) |
| Total Net Income ($ mil.) | (38.8) | (25.0) | (14.0) |
| Diluted EPS (Net Income) | (1.87) | (13.96) | (3.42) |
XTENT Stock Quote & Chart
10/10/08 14:47:22 EST •
NASDAQ •
0.88
•
 +0.0400
•
+4.7619 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
XTENT Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 2.20 | 1.54 |
| Price/Earnings Ratio | -- | 21.53 | 15.62 |
| Price/Book Ratio | 1.08 | 2.18 | 1.49 |
| Price/Cash Flow Ratio | -- | 15.86 | 9.59 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed XTENT Financial Ratios
XTENT Competitive Intelligence
| Boston Scientific | Johnson & Johnson | Medtronic | |
|---|---|---|---|
| Annual Sales ($ mil.) | 8,357.0 | 61,095.0 | 13,515.0 |
| Employees | 27,500 | 119,200 | 40,000 |
| Market Cap ($ mil.) | 18,734.7 | 198,797.7 | 63,007.2 |
Competitive Landscape
